Healthcare & Life Sciences
Remedy Pharmaceuticals, Inc.
United Stateswww.remedypharmaceuticals.com/
aliveseries-a
series-a
Stage
1
Investors
About
Remedy Pharmaceuticals develops CIRARA, a drug candidate designed to reduce cerebral edema following Large Hemispheric Infarction (massive ischemic stroke) to improve functional outcomes and reduce mortality in affected patients.
Explore Remedy Pharmaceuticals, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.